Apyx Medical (APYX) Non-Current Assets (2010 - 2026)

Apyx Medical has reported Non-Current Assets for 17 years, with the latest figure at $6.3 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 2.88% year-over-year to $6.3 million; the trailing twelve-month figure through Mar 2026 stood at $6.3 million (down 2.88% YoY), and the FY2025 full-year result was $6.6 million, down 1.8% from the prior year.
• Non-Current Assets for Q1 2026 stood at $6.3 million, down from $6.6 million in the prior quarter.
• The five-year high for Non-Current Assets was $9.5 million in Q2 2023, with the low at $4.1 million in Q1 2023.
• Historically, Non-Current Assets has averaged $7.7 million across 5 years, with a median of $8.2 million in 2022.
• Annual changes were most pronounced in 2023 — Non-Current Assets plunged 49.91% — and 2024, when it surged 114.27%.
• Apyx Medical's Non-Current Assets stood at $8.8 million in 2022, then declined by 18.82% to $7.1 million in 2023, then decreased by 5.71% to $6.7 million in 2024, then retreated by 1.8% to $6.6 million in 2025, then declined by 4.05% to $6.3 million in 2026.
• The last three Non-Current Assets figures came in at $6.3 million (Q1 2026), $6.6 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.